Huntington's Disease Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Safety and Efficacy of AMT-130 in European Adults With Early Manifest Huntington Disease
Condition: Huntington Disease Intervention: Genetic: intra-striatal rAAV5-miHTT Sponsor: UniQure Biopharma B.V. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2022 Category: Research Source Type: clinical trials
